IPCA Laboratories Ltd continues to pile up shares of Lyka Labs Ltd

One of India's leading pharmaceutical company IPCA Laboratories Ltd (IPCA) continued to acquire more shares of another listed pharmaceutical company Lyka Labs Ltd for the second day. IPCA purchased 1,774,142 equity shares of Lyka Labs Ltd through market purchase on Nov 23, 2021 at a price of Rs. 126.11 per share.

Dalal & Broacha Stock Broking Pvt. Ltd. has sold 798,786 equity shares at a price of Rs. 128.45 per share and Amee Parikh sold 975,356 equity shares of Lyka Labs Ltd at a price of Rs. 124.20 per share during the day.

In, last two trading sessions IPCA has purchased 2,824,142 equity shares which is almost 9.84% stake in the company.

Shares of IPCA Laboratories Limited was last trading in BSE at Rs. 2057.70 as compared to the previous close of Rs. 2030.35. The total number of shares traded during the day was 18822 in over 3573 trades.

The stock hit an intraday high of Rs. 2111.40 and intraday low of 2006.65. The net turnover during the day was Rs. 38823022.00.

Shares of Lyka Labs Limited was last trading in BSE at Rs. 129.15 as compared to the previous close of Rs. 123.00. The total number of shares traded during the day was 1801530 in over 100 trades.

The stock hit an intraday high of Rs. 129.15 and intraday low of 129.15. The net turnover during the day was Rs. 227280437.00.

Source : Equity Bulls

Keywords

IPCALaboratoriesLimited INE571A01020 IPCALAB Pharmaceuticals LykaLabsLimited INE933A01014 MarketPurchase BulkDeal